Literature DB >> 1690692

Evaluation of individual specificities of class I HLA on platelets by a newly developed monoclonal antibody.

K J Kao1, J C Scornik, C F McQueen.   

Abstract

In order to quantify each specific HLA-A or -B antigen on platelets, a monoclonal antibody against HLA heavy chains was developed and designated as 2F2 monoclonal antibody. This monoclonal antibody reacted on Western blot with platelet HLA from each of 10 individuals with different HLA phenotypes and precipitated all 35S-methionine-labeled HLA-A and -B antigens from three different Epstein-Barr Virus--transformed lymphoblastoid cell lines. The results indicate that the 2F2 monoclonal antibody recognizes an epitope shared by different HLA-A and -B antigens. The quantitative variation of specific HLA antigens on platelets was then studied in nine different donors by isoelectric-focusing gel electrophoresis and immunoblot using the 2F2 monoclonal antibody. The results of our studies showed that the shared HLA antigens such as A2, B35, and B62, varied three- to fivefold among different individuals and individual HLA-A or -B antigen was not equally expressed on a person's platelets. The relative quantities of specific HLA-A and -B antigens on lymphocytes were also noted to be the same as those on platelets. The finding suggests that differential expression of HLA specificities may not be restricted to platelets but is a more general phenomenon including other nucleated cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1690692     DOI: 10.1016/0198-8859(90)90080-9

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  1 in total

1.  Pure Red Cell Aplasia in Major ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Severe Pancytopenia.

Authors:  Fleur M Aung; Benjamin Lichtiger; Gabriela Rondon; C Cameron Yin; Amin Alousi; Sairah Ahmed; Borje S Andersson; Qaiser Bashir; Stefan O Ciurea; Chitra Hosing; Roy Jones; Partow Kebriaei; Issa Khouri; Yago Nieto; Betul Oran; Simrit Parmar; Muzaffar Qazilbash; Nina Shah; Elizabeth J Shpall; Richard E Champlin; Uday Popat
Journal:  Biol Blood Marrow Transplant       Date:  2016-02-26       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.